By Rob Verkerk PhD, executive & scientific director, ANH-Intl
A staggering, nearly 200,000 people (191,740 to be precise) in the UK submitted responses to a consultation run by the UK’s Department of Health & Social Care, headed by the Health Secretary Matt Hancock. This torrent of responses was made during a deliberately narrow window, from 28 August to 18 September. The consultation clearly piqued people's interest, asking the public and stakeholders for views on the Government's proposed changes to UK medicines law to prepare the way for mass vaccination against Covid-19 disease and flu.
Ask and ignore
The majority of consultations get a light sprinkling of responses, typically a lot fewer than 100, often less than 20. So it’s important to get some sense of the numbers of people who saw fit to respond within this very narrow 3-week time frame. The one-fifth of a million who responded represents 0.4%, or 400 in every 100,000, of the adult population. That’s nearly 5 times all the adults who have died with (not of) Covid in the UK since the pandemic broke in March, based on official figures.
It’s also about the same case rate that the Government has declared for the UK hotspot of Liverpool – but imagine this same density spread over the entire four countries of England, Wales, Scotland and Northern Ireland. We’d like to think that our ‘Say it Now, Don’t Regret it Later’ campaign had something to do with this. It was, after all, the most visible campaign alongside that of the journalist-run Mirror Project.
Given the scale of the response, you’d expect the Government to be listening keenly. So what did the Department of Health officials and our elected executive authority do with these responses? The answer: nothing. Zilch, Nada. They went ahead as if no one had objected.
But drafting legislation is one thing – getting it through Parliament is another. Unfortunately, not in this case, at this time. It turns out that democracy gets suspended when it’s likely to get in the way. Two factors work together to give the Government sweeping authoritarian powers. The first is the World Health Organization’s cavernous and controversial definition of a ‘pandemic’ that no longer requires severity or deaths to describe it. The second is the UK-specific, recently renewed Coronavirus Act 2020 that swept through Parliament almost unopposed, 330 for and only 24 against.
These two things hand the Government powers that have been described as “the biggest restriction on civil liberties in a generation”. They mean that dialogue between different scientific factions, the need to justify and be accountable for measures that decimate lives, livelihoods, education and the economy, are entirely optional.
In the case of the changes to the medicines regulations to prepare the way for mass vaccination – it was obviously decided it was best to push it into law through the back door, especially given the scale of public sentiment that we expect would have largely opposed the changes.
The real bombshells in the amended medicines law are tucked away in the legal language of the regulations. Our four top picks are as follows:
No attempt to enforce higher levels of transparency to compensate for abbreviated testing time. The history of vaccine development is not one that is synonymous with data transparency or lack of bias. We have argued before this is a major reason why ‘vaccine confidence’ is declining, not increasing, in many regions. So how about amending the medicines regulations to overcome such issues – especially given the Covid vaccine project has been positioned as a cooperative exercise intended for the public good, including massive funding by taxpayers? We’re not so sure, especially given the lack of any attempt in the amendments to make vaccine trial data more transparent, an approach we’ve been pushing since we wrote an open letter to the UK Health Secretary in late April. A letter that remains unanswered despite reminders.
Vaccine company reps, as originally proposed, will become the most likely ‘objective bystander’ in any court cases concerning civil liability. While manufacturers have had immunity from civil liability since 1987 if the vaccine is found to cause damage or injury to a vaccinated person, this immunity applies only if there is no evidence of negligence or defectiveness in the vaccine. Understandably, what exactly represents negligence or defectivity could end up being a key battleground for anyone trying to pursue a case for damages. It then becomes a matter of opinion to be judged by the courts. Bearing this in mind, whoever is to be the ‘reasonable person’ who will represent the view of the legally appointed ‘objective bystander’ becomes all-important.
In our own response, we strenuously advocated that such so-called ‘reasonable persons’ should not be tied to the vaccine or pharma industry as they then couldn’t possibly be objective or independent. They would be more like a ‘vested interest bystander’ than an ‘objective bystander’. As a nod to the dismay that we are sure most responses would have reflected, the Government removed reference to the pharmaceutical industry. The reference now is to a person with 'relevant expertise in the subject matter of the breach’. Different words, same thing. We’re not impressed by this kind of lip service, Mr Hancock.
Drug and vaccine advertising is re-legitimised. This change will allow direct-to-consumer advertising of drugs or vaccines for the first time in the UK (or existing members of the European Union) in over half a century. This will be applied to one or more unlicensed Covid-19 vaccines, vaccines for which the true safety and effectiveness will likely still be unclear because of the unprecedented expedition of the roll-out. One thing is to get the numbers required to conduct Phase I, II and III clinical trials within a concertinaed time frame, all of which gives the Government justification to say that while the vaccine is ‘unregistered’ it is not ‘untested’. But it’s quite another thing to not have sufficient passage of time (years, not months) to be able to observe the possible manifestation of longer term effects (e.g. certain autoimmune, nervous system and other systemic effects) that have shown up with other vaccines only after years of post-licensure surveillance.
Anybody can become a vaccinator as long as they’re supervised by an “experienced vaccinator”. Leaked documents reported in The Sun newspaper suggest vaccinators will be “trainee nurses, physios and paramedics” who are anticipated to deliver “tens of thousands” of vaccinations every day in five mass vaccination centres in the UK. On top of that there will be hundreds of mobile units operated by GPs and pharmacists which will deliver vaccines to the vulnerable and care homes. The military, in turn, will apparently be involved in the massive logistical operation of delivering vaccines to the centres and mobile units under the correct storage conditions that for some vaccines could be as low as minus 80 degrees Celsius. For the UK, the widely anticipated pre-Christmas roll-out assumes the Oxford-AstraZeneca vaccine, based on an engineered, replication-deficient chimpanzee viral vector, sails through its Phase III trials and gets green lighted by the UK medicines regulator, the MHRA.
But contrary to news reports that talk about nurses, paramedics, physios, pharmacists and doctors being the vaccinators, the amended, post-consultation and final text of the Regulation doesn’t require vaccinators to have any background in the healthcare professions. This is presumably to keep options open for all eventualities, which may include shortages of healthcare professionals. But imagine how vaccinators with no healthcare background or training would respond if asked questions about the effectiveness, safety or contents of a vaccine? What if the military were called in for this particular duty? Would military personnel, who are more used to firing weapons designed to kill or maim, really be able to deliver the new generation of synthetic biology vaccines safely, painlessly and with sufficient knowledge that would allow them to legally support informed consent? Or are we just asking too much?
Let’s revisit the Magna Carta
It was around 800 years ago that the Magna Carta Libertatum (Latin for the “Great Charter of Freedoms”) was signed as a royal charter by the unpopular King John at Runnymede, near Windsor, in 1215. Despite its rocky history and subsequent revisions, that culminated in it being integrated by Edward I into English statutory law in 1297, the Magna Carta is widely viewed as the foundation of an English (albeit unwritten) constitution, protection of the rights of the public and the basis of the emerging democratic process in the developing English Parliament.
We are now at a critical time in history where government powers in relation to civil liberties need to be reviewed or the consequences could be traumatic and affect generations to come. Such reviews are likely to be accelerated by legal challenges, such as that of Simon Dolan’s now at appeal.
This requires dialogue with the public and due parliamentary process. An authoritarian Government supported by a mainstream media that acts as a propaganda mouthpiece for Government, coupled with widespread censorship of debate by social media platforms, and the suspension of parliamentary process – all factors that are very much in play today – set the seeds for deep social instability. It’s not good enough for the current Government to say ‘we can do as we like because we got in with a huge majority’.
We await with bated breath the results of the appeal by entrepreneur Simon Dolan against the disproportionate response by the UK Government in its lockdown measures. Will there be a future legal challenge over the UK’s mass vaccination programme? We now some senior lawyers who are keeping a sharp eye on this. More in due course.
But let's not give up on Parliamentarians yet - Desmond Swayne MP - is one of very few who currently gets our full support for his views on coronavirus disproportionality!
Sir Desmond Swayne MP calls out "herd stupidity" and coronavirus fearmongering in Parliament (22 October 2020)